Abstract: The present invention relates to bispecific constructs that specifically bind to immune effector cells and, simultaneously, to IL23R-carrying target cells, as well as nucleic acids, vectors, host cells, pharmaceutical compositions, and methods of production and use thereof, including such bispecific constructs for use in treating inflammatory and/or autoimmune diseases and/or cancer.

Abstract: The present invention relates to the compounds of the formula (1) and to organic electroluminescent devices, in particular blue-emitting devices, in which these compounds are used as host material or dopant in the emitting layer and/or as hole-transport material and/or as electron-transport material.

Abstract: The present application relates to a compound of a formula (I) or formula (II) which is suitable for use as functional material in an electronic device, especially as emitter material in an organic electroluminescent device.

Abstract: The present invention relates to the compounds of the formulae (1) and (2) and to organic electroluminescent devices, in particular blue-emitting devices, in which these compounds are used as host material or dopant in the emitting layer and/or as hole-transport material and/or as electron-transport material.

Abstract: The present application relates to compounds of a formula (I), to the use thereof in organic electroluminescent devices, and to processes for preparing these compounds.

Abstract: A vehicle seat comprising at least one first and one second adjustment part and a latching device is provided. The first adjustment part is formed by a backrest of the vehicle seat and the second adjustment part is formed by a seat part of the vehicle seat. The first adjustment part is lockable in a first adjustment region in a plurality of adjustment positions relative to the second adjustment part by means of the latching device, and is adjustable relative to the second adjustment part when the latching device is in a release position, for setting the backrest in its inclination with respect to the seat part. The first adjustment part is adjustable from the first adjustment region into a second adjustment region in which the backrest is folded forward in the direction of the seat part or even onto the seat part.

Abstract: The present invention relates to a compound of formula (I) or (II), which is suitable for use as functional material in an electronic device, in particular as emitter material in an organic electroluminescent device.

Abstract: A device for detecting mass particles in air flows guided in a pipe, in particular of seeds to be distributed in a seed drill. A sensor element is disposed on the pipe. The sensor element is a piezoelectric element. An impact surface is disposed on the side of the piezoelectric element facing the interior of the pipe. A damping body is arranged on the side of the piezoelectric element facing away from the interior of the pipe. A rigid base body is disposed on the side of the piezoelectric element facing away from the interior of the pipe.

Abstract: A method for producing an injection-molded product is provided, where sunflower hulls are processed into sunflower hull fibers at a maximum temperature TPFmax of less than 200° C. Then an injection-moldable composite material is produced by mixing the sunflower hull fibers with a plastic material at a maximum temperature TPCmax ofless than 200° C. Next the produced injection-moldable composite material is automatically injection-molded into an injection-molding tool such that a molded composite material is produced. The composite material introduced into the injection-molding tool has a temperature TIM of more than 200° C. in at least one section of the injection-molding tool. Then the molded composite material is removed such that the injection-molded product is produced. A corresponding injection-molded product and the use of especially prepared sunflower hull fibers as an additive are also provided.

Abstract: A vehicle seat assembly, comprising a first seat component and a second seat component, is provided. The second seat component is adjustable relative to the first seat component—preferably about a pivot axis—and a resetting device is provided, by means of which a resetting force is exerted on the second seat component in direction of a neutral position, when the second seat component is adjusted with respect to the neutral position. The resetting device at least includes the following:—a spring element in which a portion is rotated about an axis of rotation, when the second seat component is adjusted with respect to its neutral position, and the spring element thereby is tensioned, so that via the tensioned spring element at least a part of the resetting force is provided, and—a force transmission element.

Abstract: The present application relates to a substituted benzanthracene compound of a formula (I) or (II). The application furthermore relates to an electronic device which comprises the said benzanthracene compound.

Abstract: The present invention relates to novel antibody-based treatment methods, which comprise the use of antibodies with high affinity combined with high potency, particularly the use of antibodies against a particular epitope.

Abstract: The present invention relates to bispecific constructs that specifically bind to cytotoxic T cells and, simultaneously, to IL5R-carrying target cells, as well as nucleic acids, vectors, host cells, pharmaceutical compositions, and methods of production and use thereof, including the use of the bispecific constructs in treating inflammatory and/or autoimmune diseases and cancer.

Abstract: The present invention relates to novel antibody frameworks with advantageous properties.

Abstract: The present invention relates to novel antibodies, which combine high affinity with high potency, particularly novel antibodies against a novel epitope.

Abstract: The present invention relates to bispecific constructs that specifically bind to immune effector cells and, simultaneously, to IL23R-carrying target cells, as well as nucleic acids, vectors, host cells, pharmaceutical compositions, and methods of production and use thereof, including such bispecific constructs for use in treating inflammatory and/or autoimmune diseases and/or cancer.

Abstract: The present invention relates, for example, to depletion of IL23R expressing cells in the treatment of disease and, in an embodiment thereof, to bispecific constructs that specifically bind to immune effector cells and, simultaneously, to IL23R-carrying target cells, as well as nucleic acids, vectors, host cells, pharmaceutical compositions, and methods of production and use thereof, including such bispecific constructs for use in, for example, treating inflammatory and/or autoimmune diseases and/or cancer.

Abstract: A device for detecting mass particles in air flows guided in a pipe, in particular of seeds to be distributed in a seed drill. A sensor element is disposed on the pipe. The sensor element is a piezoelectric element. An impact surface is disposed on the side of the piezoelectric element facing the interior of the pipe. A damping body is arranged on the side of the piezoelectric element facing away from the interior of the pipe. A rigid base body is disposed on the side of the piezoelectric element facing away from the interior of the pipe.

Abstract: The invention relates to a method for the in situ production of fixing elements (5) on one or more substrates (4) using an adhesive to be applied in liquid form, said method having the steps of providing the substrate(s) (4), arranging a single-part or multi-part casting mold (1), filling the casting mold (1) with liquid adhesive, and curing the adhesive on the substrate(s) (4). Said method is also used with non-porous and non-transparent substrates (4) in a work step and is suitable for attaching load-bearing fixing elements (15).

Abstract: The invention relates to the lacquering of polar film substrates with a coating system consisting of several components, the single application of material resulting in a multilayer structure of the lacquer coat. The coating system is preferably aqueous and free from organohalogen and results in an improved barrier action of the films against water vapor.